Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
A breath test would be less invasive than the traditional method of using mucus or phlegm samples from the lungs of cystic ...
Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...
A Cambridge-based firm has secured investment from the Cystic Fibrosis Foundation to develop a breath test for detecting Pseudomonas aeruginosa in cystic fibrosis patients.
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
Among the candidates listed for lung transplant, those with an indication of CF decreased from 13.3% in the pre–highly ...
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback